Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.43 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.41 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20181866 | 0.82 | ALDH1A1 (0.49) | ALDH1A1L3MBTL1NPC1RAB9AHTR2C | |
| SCHEMBL20173269 | 0.79 | HTR2C (0.46) | ALDH1A1L3MBTL1NPC1RAB9AHTR2C | |
| SCHEMBL21187190 | 0.79 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1NPC1RAB9AHTR2C | |
| SCHEMBL29010239 | 0.78 | SCN4A (0.48) | ALDH1A1L3MBTL1NPC1RAB9AHTR2C | |
| SCHEMBL27812967 | 0.78 | KMT2A (0.50) | ALDH1A1L3MBTL1NPC1RAB9AP2RX4 | |
| SCHEMBL17927808 | 0.78 | CYP1A2 (0.49) | ALDH1A1L3MBTL1NPC1RAB9AP2RX4 | |
| SCHEMBL23481671 | 0.74 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1NPC1RAB9AHTR2C | |
| SCHEMBL9880601 | 0.74 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1NPC1RAB9AHTR2C | |
| SCHEMBL15500843 | 0.73 | L3MBTL1 (0.48) | ALDH1A1L3MBTL1NPC1RAB9AP2RX4 | |
| SCHEMBL20675615 | 0.72 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1NPC1RAB9AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250100-A1 | Pyrrolopyrimidines as CFTR Potentiators | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250100-A1 | Pyrrolopyrimidines as CFTR Potentiators | CFTR, P2RX1, P2RX5 | ALDH1A1 3071/4885L3MBTL1 4203/4885NPC1 1742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.